Long Term Go to Market Objectives
The impact of the pandemic has accelerated HCP demand for digital resources, it has also had a similarly profound effect on how leaders, managers and other stakeholders make decisions that affect access to medicines and bring forward new evidence. Pharma needs to reflect this in those roles responsible for stakeholder relations – be they KAMs, MSLs or FRMs – and ensure that they are part of each organization’s wider omnichannel approach. This session dives in on what omnichannel tactics are required to leverage stakeholder relations.